Figure 2.
Generation of embryonic-like stemness of PGCCs. (a) Immunofluorescence photos of OCT4, SSEA1, SOX2 and NANOG in spheroids derived from Hey-derived PGCCs cultured in stem cell medium and reattached on coverslips at different time points. sD, spheroid day. Scale bars, 50 μm. (b) Hematoxylin–eosin (H&E) staining of spheroids from regular Hey cells and PGCCs at sD7 in stem cell medium. Bottom panels are enlarged views of the boxed areas. Black arrow, anaplastic nuclei in a cyst; orange arrow, erythrocyte-like cell in cyst; blue arrow, macrophage-like cell. Scale bars, 50 μm. (c) IHC (colored by DAB, brown) showed the expression of cytokeratin (CK), fibronectin and OCT3/4 in spheroids derived from regular Hey cells and Hey-derived PGCCs. Black arrow indicates rare positive OCT3/4 cells in the middle of spheroids. Scale bars, 50 μm. (d) Immunofluorescence photos of OCT4, NANOG, SSEA1, SOX4 and SOX2 in regular MDA-HGSC-1 cells and spheroids derived from MDA-HGSC-1-derived PGCCs on recovery day 7 (sD1) in stem cell medium. Scale bars, 50 μm. (e) Immunofluorescence photos of Xist in regular Hey and MDA-HGSC-1 cells, PGCCs derived from these cells, and PGCC-derived daughter cells. Boxed regions in the two daughter panels are daughter cells with high magnification, indicated by white arrowheads. Bars, 20 μm. (f) Quantification of OCT4, NANOG and DAZL by qRT-PCR analysis in Hey and SKOV3 cells allowed recovering in regular medium at different times after paclitaxel treatment. (g) Expression of OCT4, NANOG and SOX2 in Hey- and SKOV3-derived PGCCs at different times after paclitaxel treatment, detected by western blotting.